Spots Global Cancer Trial Database for recombinant interferon alfa
Every month we try and update this database with for recombinant interferon alfa cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy | NCT00897520 | Melanoma (Skin) | recombinant int... proteomic profi... immunoenzyme te... laboratory biom... | - 120 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma | NCT00003639 | Lymphoma | recombinant int... chlorambucil dexamethasone idarubicin | 15 Years - 70 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia | NCT00004905 | Leukemia | filgrastim recombinant int... cyclophosphamid... cytarabine etoposide idarubicin peripheral bloo... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Bone Marrow Transplantation in Treating Patients With Lymphoma | NCT00002829 | Lymphoma | Recombinant Int... Cyclophosphamid... Etoposide Mesna Bone Marrow Tra... Radiation Thera... | 15 Years - 60 Years | M.D. Anderson Cancer Center | |
| Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | NCT00005987 | Multiple Myelom... | carmustine cyclophosphamid... dexamethasone etoposide filgrastim mitoxantrone hy... recombinant int... sargramostim bone marrow abl... peripheral bloo... radiation thera... | - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma | NCT00002669 | Melanoma (Skin) | aldesleukin recombinant int... cisplatin dacarbazine | 18 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium | NCT00082719 | Bladder Cancer Urethral Cancer | Recombinant Int... | - | M.D. Anderson Cancer Center | |
| Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | NCT00015912 | Recurrent Grade... Recurrent Grade... | recombinant int... thalidomide laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed | NCT00006006 | Liver Cancer | recombinant int... thalidomide | 18 Years - | National Cancer Institute (NCI) | |
| Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma | NCT00003195 | Multiple Myelom... | recombinant int... busulfan allogeneic bone... peripheral bloo... radiation thera... | 18 Years - 65 Years | Fred Hutchinson Cancer Center | |
| Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer | NCT00003063 | Colorectal Canc... | recombinant int... fluorouracil leucovorin calc... levamisole hydr... | - 75 Years | National Cancer Institute (NCI) | |
| Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma | NCT00004244 | Kidney Cancer Melanoma (Skin) | recombinant int... recombinant int... | 18 Years - | National Cancer Institute (NCI) | |
| Chemoradiation in Locally Advanced Pancreatic Cancer | NCT00262951 | Pancreatic Canc... | recombinant int... cisplatin fluorouracil radiation thera... Resection of tu... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma | NCT00002892 | Melanoma (Skin) | recombinant int... | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Lymphoma | NCT00002835 | Lymphoma | Bleomycin Sulfa... Filgrastim (G-C... Recombinant Int... Carmustine Cisplatin (CDDP... Cyclophosphamid... Cytarabine (ARA... Etoposide (VP-1... Idarubicin Ifosfamide Leucovorin Calc... Melphalan Methotrexate Methylprednisol... mitoxantrone hy... Vincristine Sul... Peripheral Bloo... Radiation Thera... | 15 Years - 59 Years | M.D. Anderson Cancer Center | |
| Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer | NCT00053807 | Kidney Cancer | aldesleukin recombinant int... fluorouracil adjuvant therap... | - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma | NCT00028886 | Multiple Myelom... | filgrastim recombinant int... cyclophosphamid... dexamethasone doxorubicin hyd... melphalan thalidomide vincristine sul... bone marrow abl... peripheral bloo... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma | NCT00003091 | Kidney Cancer Melanoma (Skin) | aldesleukin recombinant int... | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia | NCT00006343 | Leukemia | recombinant int... cytarabine imatinib mesyla... | 18 Years - 70 Years | Novartis | |
| Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma | NCT00006244 | Refractory Mult... Stage I Multipl... Stage II Multip... Stage III Multi... | melphalan recombinant int... aldesleukin in vitro-treate... | 18 Years - 69 Years | Fred Hutchinson Cancer Center | |
| Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma | NCT00003195 | Multiple Myelom... | recombinant int... busulfan allogeneic bone... peripheral bloo... radiation thera... | 18 Years - 65 Years | Fred Hutchinson Cancer Center | |
| Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis | NCT00007995 | Multiple Myelom... | filgrastim recombinant int... sargramostim busulfan cyclophosphamid... melphalan autologous bone... bone marrow abl... peripheral bloo... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer | NCT00068575 | Pancreatic Canc... | Recombinant Int... Cisplatin Fluorouracil Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma | NCT00004088 | Multiple Myelom... | filgrastim recombinant int... busulfan cyclophosphamid... melphalan pamidronate dis... thalidomide peripheral bloo... | - 65 Years | City of Hope Medical Center | |
| S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis | NCT00002849 | Multiple Myelom... | recombinant int... dexamethasone | 18 Years - | SWOG Cancer Research Network | |
| DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC | NCT00085436 | Kidney Cancer | Aldesleukin, autologous tumo... recombinant int... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma | NCT00002767 | Melanoma (Skin) | Detox-B adjuvan... recombinant int... | 18 Years - | National Cancer Institute (NCI) | |
| Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer | NCT00003063 | Colorectal Canc... | recombinant int... fluorouracil leucovorin calc... levamisole hydr... | - 75 Years | National Cancer Institute (NCI) | |
| Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia | NCT00003239 | Leukemia | Recombinant Int... Cytarabine Omacetaxine Mep... | 12 Years - | M.D. Anderson Cancer Center | |
| BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer | NCT00004122 | Bladder Cancer | BCG vaccine recombinant int... | 18 Years - | Roswell Park Cancer Institute | |
| S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia | NCT00003416 | Lymphoma | filgrastim recombinant int... dexamethasone melphalan peripheral bloo... | - 69 Years | SWOG Cancer Research Network | |
| Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia | NCT00002771 | Leukemia | recombinant int... busulfan cytarabine hydroxyurea idarubicin allogeneic bone... autologous bone... peripheral bloo... radiation thera... | - | National Cancer Institute (NCI) | |
| Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia | NCT00015847 | Leukemia | recombinant int... imatinib mesyla... | 18 Years - | OHSU Knight Cancer Institute | |
| BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer | NCT00004122 | Bladder Cancer | BCG vaccine recombinant int... | 18 Years - | Roswell Park Cancer Institute | |
| Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer | NCT00053820 | Kidney Cancer | aldesleukin recombinant int... fluorouracil | 18 Years - 81 Years | National Cancer Institute (NCI) | |
| Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma | NCT00006385 | Melanoma (Skin) | MART-1 antigen gp100 antigen incomplete Freu... recombinant int... sargramostim tyrosinase pept... | 18 Years - | National Cancer Institute (NCI) | |
| Bone Marrow Transplantation in Treating Patients With Lymphoma | NCT00002829 | Lymphoma | Recombinant Int... Cyclophosphamid... Etoposide Mesna Bone Marrow Tra... Radiation Thera... | 15 Years - 60 Years | M.D. Anderson Cancer Center | |
| Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer | NCT00003585 | Kidney Cancer | aldesleukin recombinant int... fluorouracil isotretinoin surgical proced... | - | University of New Mexico | |
| Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma | NCT00003639 | Lymphoma | recombinant int... chlorambucil dexamethasone idarubicin | 15 Years - 70 Years | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers | NCT00095862 | Breast Cancer Unspecified Adu... | allogeneic GM-C... recombinant int... cyclophosphamid... | 18 Years - 120 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia | NCT00003405 | Leukemia | recombinant int... amifostine trih... bromodeoxyuridi... cytarabine idarubicin idoxuridine isotretinoin mitoxantrone hy... | 0 Years - 70 Years | Rush University Medical Center | |
| Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer | NCT00030342 | Colorectal Canc... Kidney Cancer | recombinant int... sargramostim therapeutic aut... fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma | NCT00003152 | Lymphoma | filgrastim recombinant int... cyclophosphamid... prednisone vincristine sul... autologous bone... bone marrow abl... peripheral bloo... radiation thera... | 18 Years - 65 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma | NCT00004104 | Melanoma (Skin) | liposomal inter... polyvalent mela... recombinant int... | 18 Years - 75 Years | NYU Langone Health | |
| Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia | NCT00002771 | Leukemia | recombinant int... busulfan cytarabine hydroxyurea idarubicin allogeneic bone... autologous bone... peripheral bloo... radiation thera... | - | National Cancer Institute (NCI) | |
| Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma | NCT00003715 | Melanoma (Skin) | BCG vaccine autologous tumo... recombinant int... chemotherapy cyclophosphamid... | 18 Years - 120 Years | AVAX Technologies | |
| Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer | NCT00016042 | Colorectal Canc... Kidney Cancer | lymphokine-acti... recombinant int... sargramostim fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Biological Therapy in Treating Patients With Metastatic Cancer | NCT00002733 | Kidney Cancer Melanoma (Skin) Unspecified Adu... | aldesleukin recombinant int... therapeutic tum... cimetidine | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia | NCT00045422 | Leukemia | recombinant int... imatinib mesyla... | - | Memorial Sloan Kettering Cancer Center | |
| Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed | NCT00006006 | Liver Cancer | recombinant int... thalidomide | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia | NCT00005986 | Leukemia | busulfan cyclophosphamid... filgrastim recombinant int... in vitro-treate... peripheral bloo... radiation thera... | 18 Years - 65 Years | Masonic Cancer Center, University of Minnesota | |
| Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia | NCT00003405 | Leukemia | recombinant int... amifostine trih... bromodeoxyuridi... cytarabine idarubicin idoxuridine isotretinoin mitoxantrone hy... | 0 Years - 70 Years | Rush University Medical Center | |
| Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer | NCT00016042 | Colorectal Canc... Kidney Cancer | lymphokine-acti... recombinant int... sargramostim fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer | NCT00019474 | Extrahepatic Bi... Gastric Cancer Gastrointestina... Liver Cancer Pancreatic Canc... Small Intestine... | filgrastim recombinant int... fluorouracil hydroxyurea | 18 Years - 120 Years | Montefiore Medical Center | |
| Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer | NCT00082862 | Pancreatic Canc... | recombinant int... cisplatin gemcitabine hyd... hyperthermia tr... | 18 Years - | National Cancer Institute (NCI) | |
| Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer | NCT00054561 | Head and Neck C... | recombinant int... vitamin E isotretinoin adjuvant therap... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Biological Therapy in Treating Patients With Metastatic Cancer | NCT00002733 | Kidney Cancer Melanoma (Skin) Unspecified Adu... | aldesleukin recombinant int... therapeutic tum... cimetidine | 18 Years - | Hoag Memorial Hospital Presbyterian | |
| Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis | NCT00004196 | Melanoma (Skin) | recombinant int... lymphangiograph... Observation | 18 Years - 70 Years | University of Alabama at Birmingham | |
| Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia | NCT00002869 | Leukemia | recombinant int... cytarabine hydroxyurea | - | National Cancer Institute (NCI) | |
| Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | NCT00005847 | Prostate Cancer | recombinant int... estramustine ph... isotretinoin mitoxantrone hy... paclitaxel vinorelbine dit... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia | NCT00045422 | Leukemia | recombinant int... imatinib mesyla... | - | Memorial Sloan Kettering Cancer Center | |
| Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell Cancer | NCT00059813 | Recurrent Renal... Stage IV Renal ... | recombinant int... oblimersen sodi... pharmacological... | 19 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia | NCT00002598 | Leukemia | recombinant int... sargramostim cyclophosphamid... cytarabine etoposide methotrexate mitoxantrone hy... bone marrow abl... radiation thera... | 16 Years - | Memorial Sloan Kettering Cancer Center | |
| Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma | NCT00026416 | Sarcoma | recombinant int... thalidomide adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin | NCT00003444 | Melanoma (Skin) | recombinant int... radiation thera... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer | NCT00002773 | Pancreatic Canc... | allogeneic tumo... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery | NCT00014092 | Melanoma (Skin) | aldesleukin recombinant int... sargramostim temozolomide | 18 Years - | National Cancer Institute (NCI) | |
| STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia | NCT00006343 | Leukemia | recombinant int... cytarabine imatinib mesyla... | 18 Years - 70 Years | Novartis | |
| Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | NCT00004231 | Lymphoma | aldesleukin filgrastim recombinant int... busulfan cyclophosphamid... cytarabine doxorubicin hyd... leucovorin calc... methotrexate prednisone teniposide vincristine sul... allogeneic bone... autologous bone... peripheral bloo... | 18 Years - | Northwestern University | |
| Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | NCT00002847 | Kidney Cancer | aldesleukin recombinant int... conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors | NCT00002470 | Gastrointestina... Lung Cancer | recombinant int... fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer | NCT00002737 | Kidney Cancer | recombinant int... chemotherapy isotretinoin | 18 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC | NCT00085436 | Kidney Cancer | Aldesleukin, autologous tumo... recombinant int... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia | NCT00003416 | Lymphoma | filgrastim recombinant int... dexamethasone melphalan peripheral bloo... | - 69 Years | SWOG Cancer Research Network | |
| Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | NCT00005987 | Multiple Myelom... | carmustine cyclophosphamid... dexamethasone etoposide filgrastim mitoxantrone hy... recombinant int... sargramostim bone marrow abl... peripheral bloo... radiation thera... | - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma | NCT00002669 | Melanoma (Skin) | aldesleukin recombinant int... cisplatin dacarbazine | 18 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer | NCT00005966 | Kidney Cancer | recombinant int... thalidomide | 18 Years - | National Cancer Institute (NCI) | |
| Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma | NCT00030849 | Lymphoma | recombinant int... bexarotene | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma | NCT00004039 | Lymphoma | recombinant int... rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... | - | Hoag Memorial Hospital Presbyterian |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
